Research Paper Volume 13, Issue 5 pp 6740—6751

Interleukin-33 modulates immune responses in cutaneous melanoma in a context-specific way

class="figure-viewer-img"

Figure 4. Differentially expressed genes and enriched pathways. (A) Venn diagram depicting genes expressed at higher levels in the high IL-33 groups; bubble plots depicting upregulated KEGG pathways in the high IL-33 groups of the primary melanoma sub-cohort (B), the LN metastasis sub-cohort (C), and the other metastasis sub-cohort (D).